Borer Denton & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$609K Buy
6,640
+85
+1% +$7.44K 0.2% 52
2026
Q1
$559K Hold
6,555
0.2% 48
2025
Q4
$518K Hold
6,555
0.17% 46
2025
Q3
$524K Hold
6,555
0.17% 46
2025
Q2
$596K Hold
6,555
0.21% 46
2025
Q1
$614K Hold
6,555
0.22% 46
2024
Q4
$596K Hold
6,555
0.21% 47
2024
Q3
$680K Hold
6,555
0.23% 45
2024
Q2
$636K Hold
6,555
0.23% 42
2024
Q1
$590K Hold
6,555
0.21% 43
2023
Q4
$522K Hold
6,555
0.2% 44
2023
Q3
$466K Hold
6,555
0.19% 43
2023
Q2
$505K Hold
6,555
0.2% 45
2023
Q1
$493K Buy
6,555
+1,380
+27% +$103K 0.2% 45
2022
Q4
$408K Hold
5,175
0.18% 50
2022
Q3
$364K Buy
+5,175
New +$406K 0.18% 49

Other funds holding CL

Borer Denton & Associates's CL Position: Q2 2026 in Review

Borer Denton & Associates increased its Colgate-Palmolive (CL) stake by 1.3% in Q2 2026, buying an estimated $7.44K and bringing the position to 6,640 shares worth $609K. The position accounts for 0.2% of the portfolio, ranked #52.

Borer Denton & Associates first reported a position in CL in Q3 2022 and has held it in 16 quarters since. The position peaked at $680K in Q3 2024. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Borer Denton & Associates held 6,640 shares of Colgate-Palmolive worth $609K as of Q2 2026.
  • Borer Denton & Associates bought 85 Colgate-Palmolive shares in Q2 2026, an estimated $7.44K.
  • Colgate-Palmolive made up 0.2% of Borer Denton & Associates's portfolio in Q2 2026, its #52 holding.
  • Borer Denton & Associates first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 16 quarters since.
  • Borer Denton & Associates's Colgate-Palmolive position peaked at $680K in Q3 2024.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Borer Denton & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.